March 21, 2012: Health Canada Issued Important Safety Information on Sandoz Morphine Sulfate Injection USP
Urgent Notice – 2mg/mL (1mL) Sandoz Morphine Sulfate Injection USP – Some boxes may contain ampoules labelled as Isoproterenol Hydrochloride Injection in addition to ampoules labelled as containing morphineHealth Canada is urgently informing healthcare professionals that it has been advised by Sandoz Canada Inc. that one package of 2mg/mL (1mL) Morphine Sulfate Injection USP has been found to contain ampoules labelled as 0.2 mg/mL (1mL) Isoproterenol Hydrochloride Injection in addition to ampoules labelled as containing morphine.
More information is available on the Health Canada website:
For Healthcare Practitioners
